Bryn Mawr Trust Advisors LLC Purchases Shares of 48,505 CME Group Inc. $CME

Key Points

• Bryn Mawr Trust Advisors initiated a CME Group position by purchasing 48,505 shares valued at approximately $10.7 million. Institutional investors and hedge funds collectively own 87.75% of CME’s outstanding stock.
• CME Group reported quarterly earnings of $2.99 per share and revenue of $1.71 billion, exceeding analyst estimates. The company also declared a $1.30 quarterly dividend, equivalent to a 1.9% yield.
• Analyst sentiment remains mixed, with a consensus rating of “Hold” and an average price target of $291.81, compared with the stock’s opening price of $269.80.

Bryn Mawr Trust Advisors LLC purchased a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 48,505 shares of the financial services provider's stock, valued at approximately $10,711,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Asset Dedication LLC increased its position in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 37 shares during the period. Whipplewood Advisors LLC lifted its position in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider's stock worth $26,000 after acquiring an additional 83 shares during the period. Elkhorn Partners Limited Partnership purchased a new stake in CME Group during the 4th quarter valued at about $27,000. Hilton Head Capital Partners LLC purchased a new stake in CME Group during the 4th quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID grew its stake in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider's stock valued at $29,000 after purchasing an additional 71 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director William R. Shepard acquired 325 shares of the company's stock in a transaction dated Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director directly owned 260,442 shares of the company's stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company's stock, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of CME stock opened at $269.80 on Friday. The stock has a market cap of $97.01 billion, a PE ratio of 22.88, a price-to-earnings-growth ratio of 3.11 and a beta of 0.23. The business has a 50-day simple moving average of $250.20 and a 200-day simple moving average of $280.22. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group's revenue for the quarter was up .8% compared to the same quarter last year. During the same period last year, the company earned $2.96 earnings per share. On average, equities analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group's dividend payout ratio is currently 44.11%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CME. TD Cowen reduced their price objective on CME Group from $323.00 to $273.00 and set a "buy" rating for the company in a research note on Monday, June 22nd. Erste Group Bank lowered CME Group from a "buy" rating to a "hold" rating in a research report on Friday, June 5th. Bank of America increased their price target on shares of CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a report on Thursday, July 23rd. Keefe, Bruyette & Woods raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price target for the company in a research report on Thursday, June 18th. Finally, Raymond James Financial restated an "outperform" rating and set a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $291.81.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source